ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
大麻股
241.43
-1.5829
-0.65%
漲家數:
2
跌家數:
14
平家數:
1
市盈率:
- -
高:
246.55
開:
243.00
低:
239.56
收:
243.01
成交量:
2,455.40萬
成交額:
2.75億
市值:
582.27億
流通市值:
524.32億
資料載入中...
總覽
新聞資訊
AIM ImmunoTech公布Ampligen與阿斯利康Durvalumab聯合治療轉移性胰腺癌的二期試驗規劃里程碑
美股速递
·
昨天
Aim Immunotech Inc.盤中異動 股價大跌6.72%報1.11美元
市场透视
·
02/20
Greenlane任命Jason Hitchcock為首席執行官,推進數字資產金庫戰略
投资观察
·
02/18
Greenlane任命Jason Hitchcock為首席執行官,推動數字資產財資戰略
美股速递
·
02/18
Veru Inc.盤中異動 急速拉升5.81%
市场透视
·
02/17
梯瓦製藥與賽諾菲Duvakitug二期B階段維持治療數據展現潰瘍性結腸炎與克羅恩病具臨床意義的持久療效
美股速递
·
02/17
無人配送車、裝配式農房、不斷生長的大樓 「小鎮CBD」正在崛起
环球网
·
02/12
Greenlane Holdings Inc.子公司與Berachain Operations Corp達成代幣購買銷售協議及代幣借貸協議——SEC文件披露
美股速递
·
02/10
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4557/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4557","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4557\",,,,,undefined,":{"symbol":"BK4557","market":"US","secType":"PLATE","nameCN":"大麻股","latestPrice":241.43008,"timestamp":1771880399999,"preClose":243.013,"halted":0,"volume":24553951,"delay":0,"changeRate":-0.006514,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":-1.582916,"latestTime":"02-23 16:00:00 EST","open":243.00298,"high":246.54514,"low":239.56474,"amount":275170346.149522,"amplitude":0.028724,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1771943400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.303455,"peRate":-148.603792,"turnoverRate":0.008408,"increases":2,"decrements":14,"flats":0,"marketCap":58226796099.75,"floatMarketCap":52431682567},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4557\",,,,,undefined,":{"symbol":"BK4557","high":246.54514,"amplitude":0.028724,"preClose":243.013,"low":239.56474,"pbRate":"3.303455","latestPrice":241.43008,"volume":24553951,"delay":0,"open":243.00298,"prevYearClose":226.48174,"prevWeekClose":243.013,"prevMonthClose":237.0625,"prevQuarterClose":226.4817,"fiveDayClose":239.5535,"twentyDayClose":228.1016,"sixtyDayClose":163.0901,"secType":"PLATE","market":"US","turnoverRate":0.008408,"peRate":-148.603792,"marketCap":58226796099.75,"floatMarketCap":52431682567,"timestamp":1771880399999,"nameCN":"大麻股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4557\",,,,undefined,":{"bkCode":"BK4557","up":2,"down":14,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4557\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1142732216","title":"AIM ImmunoTech公布Ampligen與阿斯利康Durvalumab聯合治療轉移性胰腺癌的二期試驗規劃里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1142732216","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142732216?lang=zh_tw&edition=fundamental","pubTime":"2026-02-23 21:58","pubTimestamp":1771855089,"startTime":"0","endTime":"0","summary":"AIM ImmunoTech Inc. 近日披露了其正在进行的二期临床试验的关键规划节点,该试验旨在评估其核心药物Ampligen与阿斯利康(AstraZeneca)的Durvalumab联合用于治疗转移性胰腺癌的疗效。公司明确了试验推进过程中的若干重要阶段,标志着该联合疗法研发进程的稳步推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","AIM","BK4139"],"gpt_icon":0},{"id":"2613296799","title":"Aim Immunotech Inc.盤中異動 股價大跌6.72%報1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613296799","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613296799?lang=zh_tw&edition=fundamental","pubTime":"2026-02-20 03:44","pubTimestamp":1771530243,"startTime":"0","endTime":"0","summary":"北京时间2026年02月20日03时44分,Aim Immunotech Inc.股票出现波动,股价大幅跳水6.72%。截至发稿,该股报1.11美元/股,成交量4.7269万股,换手率1.39%,振幅7.30%。Aim Immunotech Inc.股票所在的生物技术行业中,整体跌幅为0.47%。Aim Immunotech Inc.公司简介:AIM ImmunoTech Inc 是一家免疫制药公司,专注于研究和开发用于治疗多种癌症、病毒性疾病和免疫缺陷疾病的疗法,以及治疗目前疗法不足或未得到满足的癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022003440397a6860f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022003440397a6860f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","AIM","BK4139"],"gpt_icon":0},{"id":"1171009517","title":"Greenlane任命Jason Hitchcock為首席執行官,推進數字資產金庫戰略","url":"https://stock-news.laohu8.com/highlight/detail?id=1171009517","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171009517?lang=zh_tw&edition=fundamental","pubTime":"2026-02-18 21:03","pubTimestamp":1771419821,"startTime":"0","endTime":"0","summary":"佛罗里达州博卡拉顿,2026年2月18日——Greenlane Holdings, Inc.今日宣布,任命Jason Hitchcock为公司首席执行官,即时生效。Hitchcock先生是一位拥有超过15年经验的技术高管,擅长在SaaS、区块链基础设施和去中心化金融领域构建并扩展收入引擎。他加入之际,Greenlane正持续推进以Berachain为核心的数字资产金库战略,通过验证节点运营、质押及流动性供给等方式,将严谨的资本配置与积极的生态系统参与相结合。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMF","US3Y.BOND","US30Y.BOND","BK4159","US6M.BOND","US7Y.BOND","US2Y.BOND","TLTW","TLT","US12M.BOND","US5Y.BOND","US10Y.BOND","BK4557","GNLN"],"gpt_icon":1},{"id":"1116255679","title":"Greenlane任命Jason Hitchcock為首席執行官,推動數字資產財資戰略","url":"https://stock-news.laohu8.com/highlight/detail?id=1116255679","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116255679?lang=zh_tw&edition=fundamental","pubTime":"2026-02-18 21:01","pubTimestamp":1771419675,"startTime":"0","endTime":"0","summary":"Greenlane Holdings Inc. (简称GNLN) 宣布任命Jason Hitchcock为新任首席执行官,他将负责领导公司数字资产财资战略的深化与执行。这一人事变动旨在加速Greenlane在数字资产领域的布局,强化其财资管理能力。Hitchcock此前在金融科技和数字资产领域拥有丰富经验,预计将为公司带来创新视野和战略增长动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNLN","BK4159","BK4557"],"gpt_icon":0},{"id":"2612041664","title":"Veru Inc.盤中異動 急速拉升5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612041664","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612041664?lang=zh_tw&edition=fundamental","pubTime":"2026-02-17 22:33","pubTimestamp":1771338815,"startTime":"0","endTime":"0","summary":"北京时间2026年02月17日22时33分,Veru Inc.股票出现异动,股价快速上涨5.81%。截至发稿,该股报2.42美元/股,成交量2508股,换手率0.02%,振幅5.81%。Veru Inc.股票所在的生物技术行业中,整体涨幅为0.26%。Veru Inc.公司简介:Veru Inc. 是一家专注于开发治疗心血管代谢和炎症性疾病药物的后期临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260217223335a4ad8782&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260217223335a4ad8782&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4183","VERU","BK4557","BK4584"],"gpt_icon":0},{"id":"1173990339","title":"梯瓦製藥與賽諾菲Duvakitug二期B階段維持治療數據展現潰瘍性結腸炎與克羅恩病具臨床意義的持久療效","url":"https://stock-news.laohu8.com/highlight/detail?id=1173990339","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173990339?lang=zh_tw&edition=fundamental","pubTime":"2026-02-17 19:01","pubTimestamp":1771326072,"startTime":"0","endTime":"0","summary":"梯瓦制药与法国制药巨头赛诺菲联合宣布,其共同研发的药物Duvakitug在二期B阶段临床试验的维持治疗数据中,显示出对溃疡性结肠炎和克罗恩病患者具有临床意义的持久疗效。这一积极结果标志着该疗法在治疗这两种慢性炎症性肠病方面取得了重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4596","LU2324357040.USD","BK4585","BK4559","BK4007","BK4584","BK4557","LU1983299246.USD","BK4588","TEVA","BK4566"],"gpt_icon":0},{"id":"2610199657","title":"無人配送車、裝配式農房、不斷生長的大樓 「小鎮CBD」正在崛起","url":"https://stock-news.laohu8.com/highlight/detail?id=2610199657","media":"环球网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610199657?lang=zh_tw&edition=fundamental","pubTime":"2026-02-12 09:22","pubTimestamp":1770859320,"startTime":"0","endTime":"0","summary":"福渡镇人均可支配收入五年间增长近50%。无人配送车、装配式农房科技提升幸福感随着城乡融合发展深入推进,即将到来的这个春节,在全国各地,越来越多的现代化生活方式开始与乡村接轨。春节前,在山东乳山,新能源无人配送车正式上线运营。目前,青神县已将装配式技术全面融入农房建设,已建成装配式农房230多栋,发放农户与工匠奖补资金超1800万元,有效激发了市场活力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-02-12/doc-inhmpkar4092854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4557","BK4007","BK4113","MSOS","ACB","CBD"],"gpt_icon":0},{"id":"1108667416","title":"Greenlane Holdings Inc.子公司與Berachain Operations Corp達成代幣購買銷售協議及代幣借貸協議——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1108667416","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108667416?lang=zh_tw&edition=fundamental","pubTime":"2026-02-10 06:25","pubTimestamp":1770675922,"startTime":"0","endTime":"0","summary":"根据最新提交至美国证券交易委员会的文件显示,Greenlane Holdings Inc.旗下子公司已与Berachain Operations Corp正式签署代币购买销售协议及代币借贷协议。通过代币购买销售安排,Greenlane Holdings Inc.子公司将获得Berachain Operations Corp发行的特定代币资产;而代币借贷条款则确立了双方在流动性供给和资产利用率优化方面的合作框架。此次交易细节尚未完全公开,但SEC备案文件证实了双方已建立具有约束力的商业合作关系。市场关注点集中于此类协议对Greenlane Holdings Inc.在区块链业务布局可能产生的长期影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4159","BK4557","GNLN"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}